Stability of partial doses of omeprazole-sodium bicarbonate oral suspension

Annals of Pharmacotherapy

Volumn 41, Issue 12, 2007, Pages 1954-1961

  Johnson, Cary E ^a,b   Cober, Mary Petrea ^a,b   Ludwig, Jennifer L ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Omeprazole suspension; Pediatrics; Stability

Indexed keywords

BICARBONATE; LANSOPRAZOLE; OMEPRAZOLE;

ARTICLE; DRUG DETERMINATION; DRUG STABILITY; DRUG STORAGE; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NASOGASTRIC TUBE; POWDER; PRIORITY JOURNAL; REFRIGERATOR; SIMULATION; STOMACH JUICE; STORAGE TEMPERATURE; SUSPENSION; TABLET DISINTEGRATION; TABLET FORMULATION;

CHILD; DRUG STABILITY; GASTRIC JUICE; HUMANS; INTUBATION, GASTROINTESTINAL; OMEPRAZOLE; PROTON PUMP INHIBITORS; SODIUM BICARBONATE; SUSPENSIONS; TEMPERATURE;

EID: 36849074097     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K246     Document Type: Article

References (23)

1. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 2000;154:150-4.
2. Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 1997;151:569-72.
3. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32(suppl):S1-S31.
4. Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000;118(suppl 1):S9-31.
5. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:798-810.
6. Israel DM, Hassall E. Omeprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children. J Pediatr Gastroenterol Nutr 1998;27:568-79.
7. Tutunji MF, Qaisi AM, El-Eswed B, et al. An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of electrophile. Int J Pharm 2006;323:110-6.
8. Package insert. Zegerid (omeprazole-sodium bicarbonate). San Diego, CA: Santarus, February 2006.
9. Sharma VK. Comparison of 24-hour intragastic pH using four liquid formulations of lansoprazole and omeprazole. Am J Health Syst Pharm 1999;56(suppl):S18-21.
10. Sharma VK, Peyton B, Spears T, et al. Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate. Aliment Pharmacol Ther 2000;14:887-92.
11. Phillips JO, Metzler M, Palmieri TL, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996;24:1793-800.
12. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma Inj Infect Crit Care 1998;44:527-33.
13. Burnett JE, Balkin ER. Stability and viscosity of a flavored omeprazole oral suspension for pediatric use. Am J Health Syst Pharm 2006;63:2240-7.
14. Trissel LA. Avoiding common flaws in stability and compatibility studies of drugs. Am J Health Syst Pharm 1983;40:1159-60.
15. Trissel LA, Flora KP. Stability studies: five years later. Am J Health Syst Pharm 1988;45:1569-71.
16. Quercia RA, Chengde F, Liu X, et al. Stability of omeprazole in an extemporaneously prepared oral liquid. Am J Health Syst Pharm 1997;54:1833-6.
17. Cook-Sather SD, Harris KA, Rosetta Chiavacci R, et al. A liberalized fasting guideline for formula-fed infants does not increase average gastric fluid volume before elective surgery. Pediatr Anesth 2003;96:965-9.
18. Splinter WM, Schaefer JD, Bonn GE. Unlimited clear fluid ingestion by infants up to 2 hours before surgery is safe (abstract). Can J Anesth 1990;37(suppl):S95.
19. Agunod M, Yamaguchi N, Lopez R, et al. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 1969;14:400-14.
20. Grand RJ, Williams JB, Torti FM. Development of the human gastrointestinal tract. A review. Gastroenterology 1976;70:790-810.
21. Sandhar BK, Goresky GV, Maltby JR, et al. Effect of oral liquids and ranitidine on gastric fluid volume and pH in children undergoing outpatient surgery. J Anesth 1989;71:327-30.
22. Package insert. Prevacid SoluTab (lansoprazole). Lake Forest, IL: TAP Pharmaceuticals, Inc., September 2006.
23. Red Book 2007. Montvale, NJ: Thomson Healthcare Inc., 2007:591, 681,753.